Arkansas Medical Cannabis Sales Reach Record $291 Million in 2025, Marking Industry Rebound

Arkansas' medical marijuana market achieved a new milestone in 2025, with dispensaries across the state recording $291.1 million in sales, according to data from the Arkansas Department of Finance and Administration. This figure eclipses the previous high of $283 million set in 2023 and represents a $15 million increase from 2024, signaling renewed momentum for the industry after a temporary decline. The sales surge is notable given the market's launch in 2019 and the hurdles faced in recent years, including regulatory constraints and fluctuating patient demand

Industry representatives and state officials attribute the rebound to growing patient enrollment and increased product availability. Dispensaries sold 79,223 pounds of medical cannabis in 2025, up from 75,598 pounds the year before, reflecting higher demand and improved supply chains. Scott Hardin, spokesperson for the Arkansas Department of Finance and Administration, remarked, “The industry certainly rebounded in 2025 with a new sales record, following a decrease in sales the previous year.”

Since the inception of Arkansas’ medical marijuana program, total sales have reached $1.6 billion, underscoring the sector's economic significance. Tax revenues from the two principal taxes—a 6.5% state sales tax and a 4% privilege tax applied to both retail and wholesale transactions—generated $32.3 million in 2025 alone. Suite 443 in Hot Springs, the state’s first dispensary, continues to lead in sales performance, demonstrating the sustained role of early market entrants

Despite these positive trends, regulatory limitations continue to restrict further expansion. While state law allows for up to 40 dispensaries, only 36 were operational as of September, with officials slow to issue the final licenses. Secretary of Finance Jim Hudson has expressed no urgency to allocate the remaining dispensary licenses, and efforts to broaden access—such as legalizing drive-thru windows and easing delivery rules—were vetoed by Governor Sarah Huckabee in April 2025, who argued such measures "would expand access to usable marijuana."

Patient access is on the rise, with the Arkansas Department of Health reporting a 5.1% increase in active medical marijuana cards since February 2025, bringing the total to 115,113. However, industry observers note that the cap on dispensaries and conservative regulatory approach may be holding back even greater growth. As the market continues to mature, stakeholders are closely monitoring whether state policymakers will adapt regulations to meet increasing patient demand and foster further industry development

From the OG Lab newsroom perspective, Arkansas’ record-breaking sales in 2025 highlight both the resilience and untapped potential of the state’s medical cannabis industry. The interplay between rising patient numbers and restrictive licensing will be crucial for investors and operators to watch in the coming year. How state officials balance access and regulation will likely shape the industry's trajectory and could serve as a bellwether for medical cannabis markets in other conservative-leaning states